Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
January 06, 2026
Not intended for U.S. and UK Media
Bayer receives Breakthrough Therapy Designation in the U.S. and China for sevabertinib as a first-line treatment for patients with HER2-mutant non-small cell lung cancer
January 05, 2026
Not intended for U.S. and UK Media
Bayer to present updates on pharma growth strategy and pipeline advancements at J.P. Morgan’s 44th Annual Healthcare Conference
December 22, 2025
Not intended for U.S. and UK Media
Finerenone approved in Japan for treatment of patients with chronic heart failure
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
